// App-Quantinova.ai

: Medical Decision Analysis: Choosing Second Line Treatment in Adults with Immune Thrombocytopenia (ITP)

Researchers

Presenter

  • Barbara Skopec

Principal Investigators

  • Hollenberg P. James

  • James B. Bussel

Medical Centers

  • Department of Gastroenterology, University Medical Center Ljubljana, Ljubljana, Slovenia

  • Dept of Medicine, Weill Cornell Medicine, New York, NY

  • Department of Hematology/Oncology, Weill Cornell Medicine, New York, NY

Locations

  • Slovenia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Immune thrombocytopenia

  • Venous thrombosis

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Mycophenolic acid

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved